当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 现金流量表

润达医疗

(603108)

  

流通市值:96.59亿  总市值:96.59亿
流通股本:6.04亿   总股本:6.04亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,137,668,742.082,071,584,671.469,654,275,178.37,406,130,055.09
  收到的税费返还6,211,441.022,248,659.1310,550,903.166,487,323.92
  收到其他与经营活动有关的现金55,853,491.1829,209,454.27145,981,495.57101,966,064.08
  经营活动现金流入小计4,199,733,674.282,103,042,784.869,810,807,577.037,514,583,443.09
  购买商品、接受劳务支付的现金3,112,027,242.631,486,492,715.427,114,772,539.655,741,070,855.72
  支付给职工以及为职工支付的现金380,185,425.24206,955,724.05741,452,530.42566,050,623.38
  支付的各项税费205,064,270.9105,761,067.33559,121,620.05446,378,470.76
  支付其他与经营活动有关的现金348,660,093.21187,163,736.16748,513,507.2552,595,886.09
  经营活动现金流出小计4,045,937,031.981,986,373,242.969,163,860,197.327,306,095,835.95
  经营活动产生的现金流量净额153,796,642.3116,669,541.9646,947,379.71208,487,607.14
二、投资活动产生的现金流量:
  收回投资收到的现金154,640,00043,800,000374,855,632.92309,078,161.1
  取得投资收益收到的现金43,300,161.8117,506,367.3825,925,043.521,380,531.41
  处置固定资产、无形资产和其他长期资产收回的现金净额6,655,797.082,874,298.637,963,826.485,166,081.33
  收到的其他与投资活动有关的现金1,500,5501,500,55010,515,5003,515,500
  投资活动现金流入小计206,096,508.8965,681,216.01419,260,002.9339,140,273.84
  购建固定资产、无形资产和其他长期资产支付的现金56,690,397.7820,756,877.05229,163,441.82163,988,509.89
  投资支付的现金136,408,742.8658,922,200572,932,001307,872,000
  取得子公司及其他营业单位支付的现金--184,499.9184,499.9
  支付其他与投资活动有关的现金294,551.7358,152.0677,646,206.9577,488,554.08
  投资活动现金流出小计193,393,692.3779,737,229.11879,926,149.67549,533,563.87
  投资活动产生的现金流量净额12,702,816.52-14,056,013.1-460,666,146.77-210,393,290.03
三、筹资活动产生的现金流量:
  吸收投资收到的现金154,285.71-28,000,00018,000,000
  其中:子公司吸收少数股东投资收到的现金154,285.71---
  取得借款收到的现金3,821,142,957.21,511,489,033.29,190,935,521.636,784,794,632.58
  收到其他与筹资活动有关的现金229,680,000137,100,000813,006,201.92520,172,201.92
  筹资活动现金流入小计4,050,977,242.911,648,589,033.210,031,941,723.557,322,966,834.5
  偿还债务支付的现金4,040,624,403.291,746,904,591.758,818,652,152.776,367,686,403.28
  分配股利、利润或偿付利息支付的现金194,782,348.1592,063,788.95419,149,507.71326,880,721.93
  其中:子公司支付给少数股东的股利、利润71,875,50034,420,00081,805,69053,117,735
  支付其他与筹资活动有关的现金218,129,404.49118,883,619.92701,841,149.94576,933,737.05
  筹资活动现金流出小计4,453,536,155.931,957,852,000.629,939,642,810.427,271,500,862.26
  筹资活动产生的现金流量净额-402,558,913.02-309,262,967.4292,298,913.1351,465,972.24
四、汇率变动对现金及现金等价物的影响3,570,941.43-221,319.15-2,856,562.25-530,028.78
五、现金及现金等价物净增加额-232,488,512.77-206,870,757.77275,723,583.8249,030,260.57
  加:期初现金及现金等价物余额889,011,285.11889,065,285.11613,287,701.29613,287,701.29
  期末现金及现金等价物余额656,522,772.34682,194,527.34889,011,285.11662,317,961.86
补充资料:
  净利润-99,482,170.05-189,458,021.05-
  资产减值准备45,795.63-36,170,132.75-
  固定资产和投资性房地产折旧142,302,639.19-316,869,272.16-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧142,302,639.19-316,869,272.16-
  无形资产摊销10,244,900.18-21,140,270.09-
  长期待摊费用摊销13,938,170.7-27,756,306.35-
  处置固定资产、无形资产和其他长期资产的损失958,792.77--11,463,482.16-
  固定资产报废损失240,583.09-4,978,742.49-
  财务费用138,203,412.23-318,059,213.29-
  投资损失-47,447,216.74--109,820,881.18-
  递延所得税-17,603,552.94--29,569,256.15-
  其中:递延所得税资产减少-16,683,168.13--21,792,264.61-
    递延所得税负债增加-920,384.81--7,776,991.54-
  存货的减少-259,001,591.83--72,592,557.32-
  经营性应收项目的减少-178,485,255.71--115,067,333.81-
  经营性应付项目的增加348,666,438.55--66,980,258.91-
  现金的期末余额656,522,772.34-889,011,285.11-
  减:现金的期初余额889,011,285.11-613,287,701.29-
  现金及现金等价物的净增加额-232,488,512.77-275,723,583.82-
公告日期2025-08-272025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑